355 related articles for article (PubMed ID: 31344033)
1. Leishmania tarentolae: Taxonomic classification and its application as a promising biotechnological expression host.
Klatt S; Simpson L; Maslov DA; Konthur Z
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007424. PubMed ID: 31344033
[TBL] [Abstract][Full Text] [Related]
2. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
Niimi T
Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
[TBL] [Abstract][Full Text] [Related]
3. Leishmania tarentolae molecular signatures in a 300 hundred-years-old human Brazilian mummy.
Novo SP; Leles D; Bianucci R; Araujo A
Parasit Vectors; 2015 Feb; 8():72. PubMed ID: 25649153
[TBL] [Abstract][Full Text] [Related]
4. Potential application of Leishmania tarentolae as an alternative platform for antibody expression.
Lai JY; Klatt S; Lim TS
Crit Rev Biotechnol; 2019 May; 39(3):380-394. PubMed ID: 30720351
[TBL] [Abstract][Full Text] [Related]
5. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
[TBL] [Abstract][Full Text] [Related]
6. Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
Azizi H; Hassani K; Taslimi Y; Najafabadi HS; Papadopoulou B; Rafati S
Parasitology; 2009 Jun; 136(7):723-35. PubMed ID: 19416551
[TBL] [Abstract][Full Text] [Related]
7. Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species.
Raymond F; Boisvert S; Roy G; Ritt JF; Légaré D; Isnard A; Stanke M; Olivier M; Tremblay MJ; Papadopoulou B; Ouellette M; Corbeil J
Nucleic Acids Res; 2012 Feb; 40(3):1131-47. PubMed ID: 21998295
[TBL] [Abstract][Full Text] [Related]
8. RNA polymerase I promoter and splice acceptor site recognition affect gene expression in non-pathogenic Leishmania species.
Orlando TC; Mayer MG; Campbell DA; Sturm NR; Floeter-Winter LM
Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):891-4. PubMed ID: 18060313
[TBL] [Abstract][Full Text] [Related]
9. Expression of multisubunit proteins in Leishmania tarentolae.
Sugino M; Niimi T
Methods Mol Biol; 2012; 824():317-25. PubMed ID: 22160906
[TBL] [Abstract][Full Text] [Related]
10. Recombinant protein expression in Leishmania tarentolae.
Basile G; Peticca M
Mol Biotechnol; 2009 Nov; 43(3):273-8. PubMed ID: 19779853
[TBL] [Abstract][Full Text] [Related]
11. Leishmania tarentolae for the Production of Multi-subunit Complexes.
Niimi T
Adv Exp Med Biol; 2016; 896():155-65. PubMed ID: 27165324
[TBL] [Abstract][Full Text] [Related]
12. Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.
Mizbani A; Taslimi Y; Zahedifard F; Taheri T; Rafati S
Parasitol Res; 2011 Sep; 109(3):793-9. PubMed ID: 21442256
[TBL] [Abstract][Full Text] [Related]
13. Non-pathogenic trypanosomatid protozoa as a platform for protein research and production.
Breitling R; Klingner S; Callewaert N; Pietrucha R; Geyer A; Ehrlich G; Hartung R; Müller A; Contreras R; Beverley SM; Alexandrov K
Protein Expr Purif; 2002 Jul; 25(2):209-18. PubMed ID: 12135552
[TBL] [Abstract][Full Text] [Related]
14. Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay.
Baechlein C; Meemken D; Pezzoni G; Engemann C; Grummer B
J Virol Methods; 2013 Oct; 193(1):238-43. PubMed ID: 23747546
[TBL] [Abstract][Full Text] [Related]
15. Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum.
Habibzadeh S; Doroud D; Taheri T; Seyed N; Rafati S
Iran Biomed J; 2021 Sep; 25(5):349-58. PubMed ID: 34481426
[TBL] [Abstract][Full Text] [Related]
16. A novel chemically defined medium for the biotechnological and biomedical exploitation of the cell factory Leishmania tarentolae.
Cattaneo GM; Varotto-Boccazzi I; Molteni R; Ronchetti F; Gabrieli P; Mendoza-Roldan JA; Otranto D; Montomoli E; Bandi C; Epis S
Sci Rep; 2024 Apr; 14(1):9562. PubMed ID: 38671070
[TBL] [Abstract][Full Text] [Related]
17. A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery.
Pineda T; Valencia Y; Flórez MF; Pulido SA; Vélez ID; Robledo SM
Parasitology; 2016 Aug; 143(9):1133-42. PubMed ID: 27174193
[TBL] [Abstract][Full Text] [Related]
18. Comparison of several lizard Leishmania species and strains in terms of kinetoplast minicircle and maxicircle DNA sequences, nuclear chromosomes, and membrane lipids.
Gomez-Eichelmann MC; Holz G; Beach D; Simpson AM; Simpson L
Mol Biochem Parasitol; 1988 Jan; 27(2-3):143-58. PubMed ID: 3344003
[TBL] [Abstract][Full Text] [Related]
19. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a Leishmania tarentolae strain for site-directed in vivo biotinylation of recombinant proteins.
Klatt S; Hartl D; Fauler B; Gagoski D; Castro-Obregón S; Konthur Z
J Proteome Res; 2013 Dec; 12(12):5512-9. PubMed ID: 24093329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
